Cargando…

Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report

RATIONALE: Antimelanoma differentiation-associated gene 5 antibody (anti-MDA5 Ab)-positive clinically amyopathic dermatomyositis (cADM) is frequently complicated with interstitial lung disease (ILD) and has a poor prognosis. Although the short-term prognosis of anti-MDA5 Ab-positive cADM is poor, it...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishikawa, Yuichi, Kasuya, Tadamichi, Fujiwara, Michio, Kita, Yasuhiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	6900
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489601/ https://www.ncbi.nlm.nih.gov/pubmed/32925726 http://dx.doi.org/10.1097/MD.0000000000021943

Ejemplares similares

Immune checkpoint inhibitor-induced refractory polyarthritis rapidly improved by sarilumab and monitoring with joint ultrasonography: A case report
por: Abe, Kazuya, et al.
Publicado: (2022)

A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus
por: Ishikawa, Yuichi, et al.
Publicado: (2018)

Fatal and extensive multiorgan hemorrhages in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: An autopsy case report
por: Watanabe, Tsuyoshi, et al.
Publicado: (2020)

Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report
por: Endo, Yushiro, et al.
Publicado: (2018)

AB019. Response to tofacitinib in a case of refractory TIF-1 positive amyopathic dermatomyositis with arthritis
por: Jasmine, Sion Ward, et al.
Publicado: (2021)

Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report
por: Endo, Yushiro, et al.
Publicado: (2018)

Association between clinical phenotypes of dermatomyositis and polymyositis with myositis-specific antibodies and overlap systemic autoimmune diseases
por: Chiang, Hui-Ling, et al.
Publicado: (2021)

Extended-release tofacitinib for refractory Behçet disease: A case report
por: Wang, Chrong-Reen, et al.
Publicado: (2022)

Panniculitis associated with amyopathic dermatomyositis
por: Azevedo, Paula de Oliveira, et al.
Publicado: (2018)

Pruritus in patients with amyopathic dermatomyositis
por: Poddighe, Dimitri, et al.
Publicado: (2019)

Clinically Amyopathic Juvenile Dermatomyositis
por: Yıldırım, Deniz Gezgin, et al.
Publicado: (2023)

Herpes Zoster in rheumatoid arthritis patients receiving tofacitinib, a single center experience from Taiwan
por: Chen, Yen-Ju, et al.
Publicado: (2020)

Pregnancy course and outcomes of patients with polymyositis and dermatomyositis (PM/DM) managed in a single center
por: Mino, Rina, et al.
Publicado: (2022)

Amyopathic dermatomyositis with diffuse lung disease
por: Bandi, Sumeera, et al.
Publicado: (2020)

Increased Risk of Herpes Zoster Following Dermatomyositis and Polymyositis: A Nationwide Population-Based Cohort Study
por: Tsai, Shin-Yi, et al.
Publicado: (2015)

Malignancy in dermatomyositis: A retrospective paired case–control study of 202 patients from Central China
por: Chang, Lili, et al.
Publicado: (2020)

Cutaneous Features of Anti-MDA-5 Antibody-Positive Amyopathic Dermatomyositis in a Sudanese Patient
por: Alqahtani, Nouf, et al.
Publicado: (2021)

Clinically Amyopathic Dermatomyositis Caused by a Tattoo
por: Han, Bing, et al.
Publicado: (2018)

Case report: remarkable remission of SAPHO syndrome in response to Tripterygium wilfordii hook f treatment
por: Li, Chen, et al.
Publicado: (2017)

Takayasu Arteritis With Antiphosphatidylserine/Prothrombin Antibody-Positive Antiphospholipid Syndrome: Case Report and Literature Review
por: Fukui, Shoichi, et al.
Publicado: (2015)

Rapid induction of clinical remission in SAPHO syndrome using high-dose Tripterygium glycosides: A case report
por: Gong, Liang, et al.
Publicado: (2020)

Clinically amyopathic dermatomyositis associated with anti-nuclear matrix protein 2 antibody
por: Abe, Saori, et al.
Publicado: (2021)

Antimelanoma differentiation-associated gene 5 dermatomyositis associated with acute encephalopathy
por: Nguyen, Morgan, et al.
Publicado: (2021)

High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): A multicenter randomized clinical trial
por: Li, Ru, et al.
Publicado: (2016)

A case of chronic eosinophilic pneumonia associated with rheumatoid arthritis in glucocorticoid-free remission with JAK inhibitor: A case report
por: Yamane, Takashi, et al.
Publicado: (2023)

Paget's Disease of the Breast in a Patient with Amyopathic Dermatomyositis
por: Yasar, Sirin, et al.
Publicado: (2012)

A Case of Amyopathic Dermatomyositis with Pneumomediastinum and Subcutaneous Emphysema
por: Gürün Kaya, Aslıhan, et al.
Publicado: (2015)

Pneumomediastinum in MDA5-associated clinically amyopathic dermatomyositis
por: Kotsiou, Ourania S., et al.
Publicado: (2017)

Clinically amyopathic dermatomyositis during the COVID-19 pandemic
por: Kitamura, Masakazu, et al.
Publicado: (2021)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

Anti‐MDA5 antibody‐positive clinically amyopathic dermatomyositis with diffuse alveolar damage diagnosed by transbronchial lung cryobiopsy: A case report
por: Ishihara, Hiroyuki, et al.
Publicado: (2021)

Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody
por: Kishida, Dai, et al.
Publicado: (2021)

Toxic epidermal necrolysis–like dermatomyositis associated with antimelanoma differentiation antigen 5
por: Kushnir-Grinbaum, Daniella, et al.
Publicado: (2018)

Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease
por: Scirocco, Chiara, et al.
Publicado: (2020)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

Tumoral Calcinosis as an Initial Complaint of Juvenile-Onset Amyopathic Dermatomyositis
por: Doh, Eun Jin, et al.
Publicado: (2016)

Risk factors of interstitial lung diseases in clinically amyopathic dermatomyositis
por: Gan, Yu-Zhou, et al.
Publicado: (2020)

Research progress on amyopathic dermatomyositis associated with interstitial lung disease
por: Bai, Yu, et al.
Publicado: (2020)

Anti-MDA5 Antibody-positive Clinically Amyopathic Dermatomyositis Complicated by Unilateral Right-sided Interstitial Lung Disease
por: Kori, Mayuko, et al.
Publicado: (2020)

Clinically amyopathic dermatomyositis with interstitial lung disease double-positive for anti-MDA5 and anti-PL12 antibodies
por: Hiramatsu, Toshiya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6eb891fqb0s0inmd1takr8f6q1